PeptidePedia The community reference

Missed dose (revision 2)

Old revision·20:01, 29 Sep 2024·MicrodoseMagnus

This is an old revision of this page, as it stood at 20:01, 29 Sep 2024, saved by MicrodoseMagnus with the summary add the note about drawing air before withdrawal. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Missed dose
Governing quantityHalf-life relative to dosing interval
Weekly agentsLong half-life; concentration falls slowly
Daily agentsSteady state re-established within days
Topic infobox · conventions

A missed dose is a scheduled administration that is not taken. How much it matters depends almost entirely on the ratio between the drug's half-life and its dosing interval: a long half-life relative to the interval means concentrations fall slowly and a single omission changes exposure little.[1]

For a weekly agent with a half-life of several days, the concentration at the end of a normal dosing interval has fallen to a substantial fraction of its peak, and a missed week extends that decline rather than producing a sudden loss of exposure. For a daily agent with a half-life of hours, a missed day is a larger proportional change but is corrected within a day or two of resuming.[2]

References

  1. ^ Drucker DJ. "Mechanisms of action and therapeutic application of glucagon-like peptide-1." Cell Metabolism 27(4):740–756 (2018). PMID 29617641.
  2. ^ Knudsen LB, Lau J. "The discovery and development of liraglutide and semaglutide." Frontiers in Endocrinology 10:155 (2019). PMID 31031702.